Evidence map›Paper›PMID 33746206›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2021

Concordant neurophysiological signatures of cognitive control in humans and rats.

Mykel A Robble, Hans S Schroder, Brian D Kangas, Stefanie Nickels, Micah Breiger, Ann M Iturra-Mena, Sarah Perlo, Emilia Cardenas, Andre Der-Avakian, Samuel A Barnes and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Behavioral and neurophysiological signatures of cognitive control in humans and rats.The international journal of neuropsychopharmacology · 2024
    Article
  7. Human laboratory models of reward in substance use disorder.Pharmacology, biochemistry, and behavior · 2024
    Review
  8. Article
  9. Comparable roles for serotonin in rats and humans for computations underlying flexible decision-making.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  10. Translational In Vivo Assays in Behavioral Biology.Annual review of pharmacology and toxicology · 2024
    Review
  11. Biomarker Methodologies: A NIMH Perspective.Advances in neurobiology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Prefrontal cortex and depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Mykel A Robble *McLean Hospital & Harvard Medical School, Belmont, MA, USA.
Hans S Schroder *McLean Hospital & Harvard Medical School, Belmont, MA, USA.
Brian D KangasMcLean Hospital & Harvard Medical School, Belmont, MA, USA.
Stefanie NickelsMcLean Hospital & Harvard Medical School, Belmont, MA, USA.
Micah BreigerMcLean Hospital & Harvard Medical School, Belmont, MA, USA.
Ann M Iturra-MenaMcLean Hospital & Harvard Medical School, Belmont, MA, USA.
Sarah PerloMcLean Hospital & Harvard Medical School, Belmont, MA, USA.
Emilia CardenasMcLean Hospital & Harvard Medical School, Belmont, MA, USA.
Andre Der-AvakianUniversity of California San Diego, La Jolla, CA, USA.
Samuel A BarnesUniversity of California San Diego, La Jolla, CA, USA.
Stefan LeutgebUniversity of California San Diego, La Jolla, CA, USA.
Victoria B RisbroughUniversity of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-8347-3820
Gordana VitalianoMcLean Hospital & Harvard Medical School, Belmont, MA, USA.
Jack BergmanMcLean Hospital & Harvard Medical School, Belmont, MA, USA.
William A CarlezonMcLean Hospital & Harvard Medical School, Belmont, MA, USA.ORCID http://orcid.org/0000-0002-4162-3947
Diego A PizzagalliMcLean Hospital & Harvard Medical School, Belmont, MA, USA. dap@mclean.harvard.edu.ORCID http://orcid.org/0000-0002-7772-1143
Harvard University · USUniversity of California San Diego · US

Funding

Roles of nuleus accumbens CREB and Kappa function in depressionR01MH063266 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI CARLEZON, WILLIAM A. · 2001 to 2025
$9.1M
Novel Cross-Species Neurophysiological Assays of Reward and Cognitive DomainsUH3MH109334 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2018 to 2021
$1.8M
Novel Cross-Species Neurophysiological Assays of Reward and Cognitive DomainsUH2MH109334 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2016 to 2017
$1.5M
NIMH NIH HHS R01 MH063266NIMH NIH HHS UH2 MH109334NIMH NIH HHS UH3 MH109334
6 · The paper itself

Abstract

Progress towards understanding neural mechanisms in humans relevant to psychiatric conditions has been hindered by a lack of translationally-relevant cognitive tasks for laboratory animals. Accordingly, there is a critical need to develop parallel neurophysiological assessments of domains of cognition, such as cognitive control, in humans and laboratory animals. To address this, we developed a touchscreen-based cognitive (Eriksen Flanker) task in rats and used its key characteristics to construct a novel human version, with similar testing parameters and endpoints across species. We obtained continuous electroencephalogram (EEG) recordings, including local field potentials in rats, and compared electrophysiological signatures locked to stimulus onset and responses across species. We also assessed whether behavioral or physiological task effects were modulated by modafinil, which enhances aspects of cognitive function in humans. In both species, the task elicited expected flanker interference effects (reduced accuracy) during high-conflict trials. Across homologous neuroanatomical loci, stimulus-locked increases in theta power during high-conflict trials as well as error-related negative potentials were observed. These endpoints were not affected by modafinil in either species. Despite some species-specific patterns, our findings demonstrate the feasibility of a rat Flanker task as well as cross-species behavioral and neurophysiological similarities, which may enable novel insights into the neural correlates of healthy and aberrant behavior and provide mechanistic insights relevant to treatment.

Indexed as

CognitionElectroencephalographyAnimalsHumansRatsReaction Time

Identifiers

PMID33746206
PMCPMC8134486
OpenAlexW3137649860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.